Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Moderna and Pfizer Investors: There's Room For Multiple mRNA Coronavirus Vaccine Winners

TheMotleyFool

0 0

Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate. This news, paired with the equally impressive data from Moderna (NASDAQ: MRNA) about its candidate that takes a similar approach, inspired much hope around the world and injected optimism into the stock market.

The Motley Fool talked to Dr. Leo Nissola about what this hopeful development means for the world and for investors.

Source Fool.com

Like: 0

MRNA

Share